Abundance Wealth Counselors’s Biocept, Inc. BIOC Stock Holding History

Abundance Wealth Counselors’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	–	–	370
2021 Q1	$0	Buy	+1	New	+$182	﹤0.01%	377

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Abundance Wealth Counselors's BIOC Position: Q2 2021 in Review

Abundance Wealth Counselors sold out of Biocept, Inc. (BIOC) in Q2 2021, closing a stake of 1 share.

Abundance Wealth Counselors first reported a position in BIOC in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 21 funds tracked by Wall St. Rank hold BIOC as of Q2 2021.

Abundance Wealth Counselors reported no remaining Biocept, Inc. position as of Q2 2021 after selling out during the quarter.
Abundance Wealth Counselors sold 1 Biocept, Inc. share in Q2 2021.
Abundance Wealth Counselors first reported a position in Biocept, Inc. in Q1 2021 and held it in 1 quarter.
Abundance Wealth Counselors's Biocept, Inc. position peaked at $0 in Q1 2021.
21 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2021.

Based on Abundance Wealth Counselors's 13F filing for Q2 2021, filed 21 Jul 2021.